Back Pain Clinical Trial
Official title:
Determining the Impact of a New Physiotherapist Led Primary Care Model for Back Pain: A Pilot Cluster Randomized Controlled Trial
Verified date | March 2019 |
Source | Queen's University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a pilot cluster randomized controlled trial to determine the feasibility of a cluster randomized trial to evaluate the individual and health system impact of implementing a new physiotherapist-led primary care model for back pain in Canada.
Status | Completed |
Enrollment | 100 |
Est. completion date | January 15, 2019 |
Est. primary completion date | January 15, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adults (18 years and over) with back pain of any duration - Seeking primary care for back pain at a participating site - Primary care visit may be a first or repeat visit Exclusion Criteria: - Patients who do not consent to participation - Patients who report being unable to understand, read, and write English |
Country | Name | City | State |
---|---|---|---|
Canada | Queen's University | Kingston | Ontario |
Lead Sponsor | Collaborator |
---|---|
Queen's University | Canadian Institutes of Health Research (CIHR) |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment of primary care teams | Ability to recruit four primary care teams (Family Health Teams or Community Health Centres) to paricipate | Baseline | |
Primary | Recruitment of patient participants | Recruitment rate (participants/week) or total number of participants recruited in 14 weeks | Baseline to 14 weeks | |
Primary | Assessment completion | Percentage of all assessment items completed by participants completing each assessment | Baseline, 6-week 12-week, 6,9,12 month follow-up. The primary time point for this assessment is 12-week follow-up. | |
Primary | Retention of patient participants | Attrition rate | Retention of participants at 6-week, 12-week, 6, 9, and 12-month follow-up assessments. The primary timeline for this outcome is 12-month follow-up. | |
Primary | Physiotherapist confidence in carrying out the interventions | The PT will rate his/her confidence in each component of the intervention after the training on a scale from 0-10 with higher scores indicating greater confidence in carrying out that component of the intervention. | Baseline | |
Primary | Treatment fidelity | Treatment fidelity will be measured by consistency with the intervention described in the protocol measured through an intervention checklist completed by the physiotherapist and an audit of the EMR notes. | 6-week follow-up | |
Secondary | Self-reported disability | measured using the Roland Morris Disability Questionnaire (0 to 24 with higher scores indicating greater disability) | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Self-reported pain intensity | measured using a numeric pain rating scale from 0 to 10 with higher scores indicating greater pain intensity (measured at rest, during walking, and during a lifting task) | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Health Related Quality of Life | measured using the EuroQoL-5D-5L (0 to 100 with greater scores indicating greater self-reported health related quality of life) | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Global rating of change | measured using an 11-point scale (-5 to +5 with negative scores indicating a worsening of physical functioning related to back pain and positive scores indicating an improvement of physical functioning related to back pain) | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Satisfaction with health care | measured using an 11-point scale(-5 to +5 with negative scores indicating a dissatisfaction with health care received and positive scores indicating satisfaction with health care received) | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Catastrophic Thinking | measured using the Pain Catastrophizing Scale (0 to 52 with higher scores indicating greater catastrophic thinking) | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Depressive symptoms | measured using the 9-item Patient Health Questionnaire (PHQ-9) (0 to 27 with greater scores indicating increased depressive symptoms) | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Adverse events | measured using an adverse events questionnaire that asks 1) if the patient has experienced any adverse events as a result of the treatments received (yes/no); 2) how long the event lasted (hours or days); 3) how severe the adverse event was (0-10 scale); 4) what adverse events were experienced. | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Health care accessibility | Percentage of patients receiving care within 48 hours. | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Health care accessibility | Percentage of patients who score medium or high risk on the STarT Back tool who receive physiotherapy care. | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Health care utilization | All health care visits (aggregated and dis-aggregated) including: primary care visits, emergency department visits, hospitalizations, surgeries, consultations with other health care providers, diagnostic imaging, medications, and other care received by the patient | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Costs (piloted for a cost utility analysis in a future trial) | Includes all health care costs plus societal costs using a human capital approach for loss of productivity | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Medications prescribed | Measured as a process outcome | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | Diagnostic imaging ordered | Measured as a process outcome | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | referrals to other health care providers made | Measured as a process outcome | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up | |
Secondary | notes made by primary care provider to employers or insurers | Measured as a process outcome | Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05982483 -
Erector Spinae Plane Block vs. Usual Care for ED Patients With Mechanical Back Pain
|
N/A | |
Completed |
NCT04744246 -
Muscle Activity During Load Carriage in ROTC Cadets
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Active, not recruiting |
NCT03680846 -
Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain
|
N/A | |
Completed |
NCT05597189 -
Clinical Study for Palliative/Preventive Treatment of Chronic Back Pain
|
N/A | |
Completed |
NCT05342181 -
Static and Dynamic Core Stability Exercises in Potpartum Back Pain
|
N/A | |
Completed |
NCT02955342 -
Back and Neck Pain in Adolescence
|
||
Not yet recruiting |
NCT02536274 -
"Examination of the Impact of a Dynamic Flexion Orthosis (Dynaflex®Ottobock) or of a Back Bandage (Lumbo Sensa®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Back Pain"
|
N/A | |
Completed |
NCT02704845 -
Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain
|
N/A | |
Recruiting |
NCT02237105 -
The Effect of Cognitive Behavioral Therapy on the Outcome of Spinal Surgery
|
N/A | |
Enrolling by invitation |
NCT02485795 -
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
|
N/A | |
Terminated |
NCT02239627 -
Epidural Clonidine Versus Corticosteroid for Low Back Pain
|
N/A | |
Completed |
NCT02609009 -
Back Pain and Spinal Manipulation in Adolescent Scoliosis
|
N/A | |
Completed |
NCT02254694 -
The Influence of High Heeled Shoes on the Sagittal Balance of the Spine and Whole Body
|
N/A | |
Completed |
NCT00986180 -
NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain
|
Phase 3 | |
Completed |
NCT00771758 -
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
|
Phase 3 | |
Terminated |
NCT00769626 -
Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy
|
Phase 3 | |
Withdrawn |
NCT00231374 -
Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning
|
N/A | |
Completed |
NCT00454064 -
Cognitive-behavioural Treatment of Chronic Back Pain
|
Phase 3 | |
Completed |
NCT00103675 -
Sensor Measurement of Acupuncture Needle Manipulation
|
Phase 1 |